GlassScriptPhysician profile
Ivan F Gonzalez
NPI 1720084171
$19,674.77
in general payments reported to CMS, 2019-2025
14 companies · $447 in 2025
The $447 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,114 · 2020: $942 · 2021: $2,234 · 2022: $12K · 2023: $510 · 2024: $189 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,343.57 | 2019-2025 | Portico, Sjm Regent, Mitraclip |
| Edwards Lifesciences Corporation | $4,156.53 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $1,236.22 | 2019-2025 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $798.10 | 2019-2020 | |
| Livanova USA, INC. | $490.71 | 2019-2023 | Perfusion Tubing |
| E.R. Squibb & Sons, L.L.C. | $238.00 | 2021 | |
| Atricure, INC. | $154.96 | 2023 | |
| Bard Peripheral Vascular, INC. | $123.90 | 2022 | |
| Abiomed | $29.64 | 2023 | Impella |
| Biotronik INC. | $24.48 | 2019 | |
| Boston Scientific Corporation | $22.79 | 2023 | |
| Novartis Pharmaceuticals Corporation | $19.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.19 | 2021 | |
| Pbg Puerto Rico LLC | $18.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.